PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,882,500 | +242.0% | 825,000 | +50.0% | 1.48% | +201.0% |
| Q4 2022 | $5,813,500 | +357.8% | 550,000 | +177.2% | 0.49% | +884.0% |
| Q3 2021 | $1,270,000 | -49.5% | 198,429 | -33.5% | 0.05% | -42.5% |
| Q2 2021 | $2,516,000 | -61.9% | 298,429 | -52.6% | 0.09% | -75.1% |
| Q1 2021 | $6,612,000 | -54.6% | 630,000 | -26.7% | 0.35% | -49.2% |
| Q4 2020 | $14,557,000 | +32.0% | 859,314 | 0.0% | 0.69% | -14.6% |
| Q3 2020 | $11,025,000 | +30.2% | 859,314 | +43.2% | 0.81% | +19.0% |
| Q2 2020 | $8,467,000 | +3533.9% | 600,000 | +3744.2% | 0.68% | +2411.1% |
| Q4 2019 | $233,000 | – | 15,608 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |